Search research articles
Contact Us
Filters
Showing results (61-70 of 280) with videos related to
Page
of 28
Sort By:
BMJ (Clinical Research Ed.)
|
June 30, 2009
Managing hepatitis C virus infection
Kathryn L Nash, Ian Bentley, Gideon M Hirschfield
Journal of Hepatology
|
July 11, 2020
The 6 C's of primary sclerosing cholangitis
Maya Deeb, Tom H Karlsen, Gideon M Hirschfield
The Lancet. Gastroenterology & Hepatology
|
February 14, 2026
Antipruritic effects of the ileal bile acid transporter inhibitor linerixibat
Gideon M Hirschfield, Andreas E Kremer, Cynthia Levy
Journal of Hepatology
|
August 17, 2022
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"
Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield
The New England Journal of Medicine
|
May 29, 2024
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply
Gideon M Hirschfield, Andreas E Kremer, Cynthia Levy
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 12, 2008
Preventative hepatology: minimising symptoms and optimising care
Gideon M Hirschfield, Teru Kumagi, E Jenny Heathcote
Alimentary Pharmacology & Therapeutics
|
August 20, 2020
Review article: pathophysiology and management of primary biliary cholangitis
Kristel K Leung, Maya Deeb, Gideon M Hirschfield
Seminars in Immunopathology
|
August 2, 2014
Mechanisms of tissue injury in autoimmune liver diseases
Evaggelia Liaskou, Gideon M Hirschfield, M Eric Gershwin
Therapeutic Advances in Gastroenterology
|
December 25, 2010
Current status of therapy in autoimmune liver disease
Gideon M Hirschfield, Nadya Al-Harthi, E Jenny Heathcote
Expert Review of Clinical Pharmacology
|
November 10, 2015
Obeticholic acid for the treatment of primary biliary cirrhosis
Palak J Trivedi, Gideon M Hirschfield, M Eric Gershwin
Page
of 28
Search research articles
Search
Showing results (61-70 of 280) with videos related to
Sort By:
Page
of 28
BMJ (Clinical Research Ed.)
|
June 30, 2009
Managing hepatitis C virus infection
Kathryn L Nash, Ian Bentley, Gideon M Hirschfield
Journal of Hepatology
|
July 11, 2020
The 6 C's of primary sclerosing cholangitis
Maya Deeb, Tom H Karlsen, Gideon M Hirschfield
The Lancet. Gastroenterology & Hepatology
|
February 14, 2026
Antipruritic effects of the ileal bile acid transporter inhibitor linerixibat
Gideon M Hirschfield, Andreas E Kremer, Cynthia Levy
Journal of Hepatology
|
August 17, 2022
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"
Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield
The New England Journal of Medicine
|
May 29, 2024
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply
Gideon M Hirschfield, Andreas E Kremer, Cynthia Levy
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 12, 2008
Preventative hepatology: minimising symptoms and optimising care
Gideon M Hirschfield, Teru Kumagi, E Jenny Heathcote
Alimentary Pharmacology & Therapeutics
|
August 20, 2020
Review article: pathophysiology and management of primary biliary cholangitis
Kristel K Leung, Maya Deeb, Gideon M Hirschfield
Seminars in Immunopathology
|
August 2, 2014
Mechanisms of tissue injury in autoimmune liver diseases
Evaggelia Liaskou, Gideon M Hirschfield, M Eric Gershwin
Therapeutic Advances in Gastroenterology
|
December 25, 2010
Current status of therapy in autoimmune liver disease
Gideon M Hirschfield, Nadya Al-Harthi, E Jenny Heathcote
Expert Review of Clinical Pharmacology
|
November 10, 2015
Obeticholic acid for the treatment of primary biliary cirrhosis
Palak J Trivedi, Gideon M Hirschfield, M Eric Gershwin
Page
of 28